| D-0220-2024 | Class I | Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: I | November 17, 2023 |
| D-1272-2020 | Class III | Gabapentin Tablets USP, 600 mg, Rx Only, 500-count bottle, Manufactured for: Exelan Pharmaceuticals, | May 14, 2020 |
| D-1454-2019 | Class III | Testosterone Topical Solution 30mg of testosterone per pump actuation * each actuation delivers 1.5 | June 12, 2019 |
| D-1125-2019 | Class II | Testosterone Cypionate Injection, USP, 1000 mg/10 mL (100 mg/mL), For intramuscular use only, 10 mL | March 22, 2019 |
| D-1123-2019 | Class II | Testosterone Cypionate Injection, USP, 2000 mg/10 mL (200 mg/mL), For intramuscular use only, 10 mL | March 22, 2019 |
| D-1124-2019 | Class II | Testosterone Cypionate Injection, USP, 200 mg/mL, For IM use only, 1 mL Vial, Single Dose, Rx Only, | March 22, 2019 |
| D-0012-2019 | Class III | Amlodipine Besylate USP 10 mg Tablets, 1000-count bottles, Rx Only, Manufactured by: Cipla Ltd., Ver | October 3, 2018 |
| D-1212-2018 | Class III | Bupropion Hydrochloride ER Tablets, USP 150 mg, packaged in a) 90-count bottle (NDC 69097-875-05), M | September 6, 2018 |
| D-0619-2018 | Class III | buPROPion HCl Extended-Release Tablets, USP (SR), 150 mg ,a) 60 count (NDC 69097-878-03) and b) 1 | March 15, 2018 |
| D-0618-2018 | Class III | buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 60 count bottles, Rx Only, Manufactured | March 15, 2018 |
| D-0698-2018 | Class III | Decitabine for Injection, 50mg per vial, Rx only, Manufactured by: Cipla Ltd., Verna Goa, India, Man | March 5, 2018 |